Delivery Order SPE2DB22D1017-SPE2DB25FE8GE

Award Date 10/31/24
Potential Completion Date 11/22/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of 4,568,078,577 units of the prescription medication YONSA 125 MG TABLET 120S. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,957,350 units of the prescription medication YONSA 125 MG TABLET 120S, with a ceiling value of $2,271.36. The contract is a firm fixed-price, non-set-aside delivery order with a period of performance ending on May 8, 2025. AmerisourceBergen Drug Corp holds a substantial...
This is a $4,542.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 120 tablets of the medication YONSA 125 MG with a completion date of June 10, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the supply of 4,568,235,544 units of the prescription medication YONSA 125 MG TABLET 120S. The delivery order is a firm fixed-price contract with a completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,195.48 firm-fixed-price contract is for the delivery of YONSA 125 MG tablets. The ultimate completion date for this contract is February 7, 2024. This order is not associated with a set-aside program. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of 4,567,212,894 units of the drug YONSA 125 MG TABLET 120S. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug YONSA 125 MG TABLET 120S. The contract has a ceiling value of $2,195.48 and a period of performance through July 9, 2024. It is a firm fixed-price contract, classified as a delivery order and not designated with any set-aside requirements. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 120 tablets of the prescription medication YONSA 125 MG. The contract has a firm fixed price of $2,271.36 and a completion date of July 23, 2025. AmerisourceBergen Drug Corp is a for-profit organization that has held a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, is for the delivery of 4,565,585,290 units of the drug YONSA 125 MG TABLET 120S. The $2,195.48 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on August 26, 2024, with a completion date of September 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a firm-fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,195.48, is for the procurement of 4,563,032,237 units of YONSA 125 MG TABLET 120S. The contract has a completion date of December 29, 2023 and was awarded on December 7, 2022. The contract is not set-aside and represents a standard open competition. AmerisourceBergen Drug Corp holds a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8GE
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,294,927 units of the drug YONSA (125 mg tablets, 120 count). The $2,195.48 firm fixed-price contract has a period of performance through November 2024. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the company to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 1/30/25, 9:22 AM